| Literature DB >> 24747192 |
Lisa Danquah1, Hannah Kuper1, Cristina Eusebio2, Mamunur Akm Rashid3, Liza Bowen1, Allen Foster1, Sarah Polack1.
Abstract
BACKGROUND: Cataract surgery has been shown to improve quality of life and household economy in the short term. However, it is unclear whether these benefits are sustained over time. This study aims to assess the six year impact of cataract surgery on health related quality of life (HRQoL), daily activities and economic poverty in Bangladesh and The Philippines. METHODS ANDEntities:
Mesh:
Year: 2014 PMID: 24747192 PMCID: PMC3991652 DOI: 10.1371/journal.pone.0094140
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline socio-demographic characteristics of cases and controls included in the one and six year follow-up.
| THE PHILIPPINES | BANGLADESH | |||||
| Operated cases | Controls | P-value | Operated cases | Controls | P-value | |
| n = 51 | n = 91 | n = 56 | n = 142 | |||
|
| 69.1 (66.6–71.7) | 68.3 (66.4–70.1) | 0.58 | 68.5 (66.1–70.9) | 66.7 (65.4–68.1) | 0.18 |
|
| 73% | 53% | 0.02 | 55% | 59% | 0.63 |
|
| 49% | 63% | 0.12 | 50% | 58% | 0.28 |
|
| 90% | 92% | 0.66 | 18% | 39% | 0.005 |
|
| 88% | 89% | 0.89 | 9% | 30% | 0.002 |
|
| ||||||
| ≥6/18 | 0% | 100% | N/A | 0% | 100% | N/A |
| <6/24–6/60 | 24% | 27% | ||||
| <6/60–3/60 | 20% | 20% | ||||
| <3/60 | 56% | 53% | ||||
Vision related quality of life at baseline and one and six year follow up for operated cases and controls.
| THE PHILIPPINES | BANGLADESH | |||||
| Operated cases | Controls | Operated cases | Controls | |||
| Means (95% CI) | Means (95% CI) | P-value: Cases versus controls | Means (95% CI) | Means (95% CI) | P-value: Cases versus controls | |
|
| ||||||
| Baseline | 18.6 (12.9–24.4) | 65.4 (60.1–70.7) | <0.001 | 12.5 (9.1–15.9) | 64.6 (61.6–67.7) | <0.001 |
| 1 year follow up | 75.5 (69.3–81.7) | 75.5 (69.8–81.3) | 0.99 | 75.0 (69.3–80.7) | 74.0 (70.7–77.1) | 0.74 |
| 6 year follow up | 70.1 (62.4–77.8) | 75.8 (71.0–80.6) | 0.19 | 64.5 (58.5–70.6) | 65.6 (61.7–69.5) | 0.77 |
| P-value: 1 year versus baseline | <0.001 | 0.003 | <0.001 | <0.001 | ||
| P-value: 6 year versus 1 year | 0.17 | 0.93 | <0.001 | <0.001 | ||
|
| ||||||
| Baseline | 27.1 (21.0–33.3) | 88.3 (85.4–91.1) | <0.001 | 16.8 (12.9–20.8) | 86.3 (83.8–88.8) | <0.001 |
| 1 year follow up | 86.1 (81.5–90.7) | 85.9 (82.7–89.2) | 0.95 | 82.0 (75.6–88.4) | 82.1 (79.2–85.1) | 0.95 |
| 6 year follow up | 79.6 (72.3–87.0) | 82.7 (78.7–86.8) | 0.43 | 73.8 (66.8–80.8) | 75.8 (71.9–79.7) | 0.61 |
| P-value: 1 year versus baseline | <0.001 | 0.08 | <0.001 | 0.007 | ||
| P-value: 6 year versus 1 year | 0.02 | 0.09 | <0.001 | 0.002 | ||
|
| ||||||
| Baseline | 40.4 (34.4–46.5) | 87.4 (84.1–90.6) | <0.001 | 32.7 (26.0–39.4) | 89.9 (87.4–92.4) | <0.001 |
| 1 year follow up | 83.8 (79.6–88.1) | 87.8 (84.3–91.4) | 0.16 | 85.9 (79.8–92.0) | 83.0 (79.8–86.2) | 0.36 |
| 6 year follow up | 75.9 (68.6–83.1) | 78.1 (73.5–82.7) | 0.58 | 69.9 (63.0–76.7) | 69.9 (65.5–74.1) | 0.99 |
| P-value: 1 year versus baseline | <0.001 | 0.72 | <0.001 | <0.001 | ||
| P-value: 6 year versus 1 year | 0.02 | <0.001 | <0.001 | <0.001 | ||
Proportion of respondents reporting some (any/extreme) problem with EQ-5D domains at baseline and one and six year follow up for operated cases and controls.
| THE PHILIPPINES | BANGLADESH | |||||
| Operated cases | Controls | Operated cases | Controls | |||
| n = 51 | n = 91 | n = 56 | n = 142 | |||
| EQ-5D Domain | % | % | P-value: Cases versus controls | % | % | P-value: Cases versus controls |
|
| ||||||
| Baseline | 82% | 57% | 0.002 | 88% | 43% | <0.001 |
| 1 year follow up | 59% | 52% | 0.41 | 34% | 44% | 0.18 |
| 6 year follow up | 55% | 46% | 0.32 | 44% | 36% | 0.36 |
| P-value: 1 year versus baseline | 0.01 | 0.38 | <0.001 | <0.001 | ||
| P-value: 6 year versus 1 year | 0.81 | 0.38 | 0.23 | 0.11 | ||
|
| ||||||
| Baseline | 57% | 10% | <0.001 | 66% | 18% | <0.001 |
| 1 year follow up | 31% | 23% | 0.28 | 26% | 23% | 0.60 |
| 6 year follow up | 41% | 34% | 0.40 |
|
| 0.98 |
| P-value: 1 year versus baseline | 0.01 | 0.005 | <0.001 | 0.29 | ||
| P-value: 6 year versus 1 year | 0.19 | 0.07 | 0.78 | 0.41 | ||
|
| ||||||
| Baseline | 39 (76%) | 26 (29%) | <0.001 | 50 (89%) | 60 (42%) | <0.001 |
| 1 year follow up | 23 (45%) | 26 (29%) | 0.05 | 24 (43%) | 53 (37%) | 0.47 |
| 6 year follow up | 28 (55%) | 37 (41%) | 0.10 | 23 (42%) | 46 (33%) | 0.24 |
| P-value: 1 year versus baseline | 0.01 | 1.0 | <0.001 | 0.32 | ||
| P-value: 6 year versus 1 year | 0.28 | 0.05 | 0.99 | 0.40 | ||
|
| ||||||
| Baseline | 49 (96%) | 60 (65%) | <0.001 | 44 (79%) | 120 (85%) | 0.32 |
| 1 year follow up | 38 (75%) | 65 (71%) | 0.69 | 44 (78%) | 117 (82%) | 0.53 |
| 6 year follow up | 38 (75%) | 59 (65%) | 0.24 | 49 (89%) | 120 (86%) | 0.53 |
| P-value: 1 year versus baseline | 0.005 | 0.37 | 0.99 | 0.59 | ||
| P-value: 6 year versus 1 year | 1.0 | 0.24 | 0.08 | 0.40 | ||
|
| ||||||
| Baseline | 71% | 52% | 0.03 | 91% | 78% | 0.03 |
| 1 year follow up | 61% | 41% | 0.02 | 86% | 89% | 0.46 |
| 6 year follow up | 37% | 44% | 0.42 | 91% | 91% | 0.91 |
| P-value: 1 year versus baseline | 0.25 | 0.12 | 0.32 | 0.01 | ||
| P-value: 6 year versus 1 year | <0.001 | 0.34 | 0.99 | 0.004 | ||
| Baseline | 0.003 | 0.62 | 0.32 | 0.51 | ||
Participation in different activities over the past week at baseline and one and six year follow up for operated cases and controls.
| THE PHILIPPINES | BANGLADESH | |||||
| Operated cases | Controls | Operated cases | Controls | |||
| n = 51 | n = 91 | n = 56 | n = 142 | |||
| % | % | P-value: Cases versus controls | % | % | P-value: Cases versus controls | |
|
| % | |||||
| Baseline | 80% | 97% | 0.002 | 61% | 97% | <0.001 |
| 1 year follow up | 94% | 96% | 0.70 | 88% | 94% | 0.13 |
| 6 year follow up | 88% | 88% | 0.96 | 79% | 83% | 0.46 |
| P-value: 1 year versus baseline | 0.02 | 0.65 | 0.001 | 0.15 | ||
| P-value: 6 year versus 1 year | 0.18 | 0.02 | 0.09 | 0.001 | ||
|
| ||||||
| Baseline | 47% | 45% | 0.82 | 43% | 40% | 0.73 |
| 1 year follow up | 67% | 77% | 0.18 | 70% | 70% | 0.99 |
| 6 year follow up | 65% | 70% | 0.49 | 45% | 44% | 0.90 |
| P-value: 1 year versus baseline | 0.03 | <0.001 | 0.007 | <0.001 | ||
| P-value: 6 year versus 1 year | 0.81 | 0.32 | 0.01 | <0.001 | ||
|
| ||||||
| Baseline | 29% | 11% | 0.008 | 39% | 6% | <0.001 |
| 1 year follow up | 5% | 3% | 0.19 | 14% | 9% | 0.29 |
| 6 year follow up | 12% | 15% | 0.55 | 11% | 10% | 0.86 |
| P-value: 1 year versus baseline | <0.001 | 0.03 | 0.004 | 0.35 | ||
| P-value: 6 year versus 1 year | 0.01 | 0.002 | 0.48 | 0.8 | ||
Figure 1Time (minutes) spent on productive activities at baseline, one year and six year follow up among operated cases and controls.
Per capita expenditure (PCE), assets and self-rated wealth at baseline and one and six year follow up for operated cases and controls.
| THE PHILIPPINES | BANGLADESH | |||||
| Operated cases | Controls | Operated cases | Controls | |||
| Means (95% CI) | Means (95% CI) | P-value: Cases versus controls | Means (95% CI) | Means (95% CI) | P-value: Cases versus controls | |
|
| ||||||
| Baseline | 21.73 (3.97–57.51) | 29.01 (2.54–184.17) | 0.04 | 14.95 (12.34–17.56) | 26.90 (13.21–40.60) | 0.02 |
| 1 year follow up | 27.1 (5.37–134.39) | 28.13 (3.27–108.14) | 0.50 | 23.05 (16.55–29.56) | 21.24 (19.42–23.07) | 0.37 |
| 6 year follow up | 38.9 (3.9–246.62) | 37.4 (3.53–197.36) | 0.85 | 23.29 (17.88–30.09) | 24.29 (20.84–27.73) | 0.85 |
| P-value: 1 year versus baseline | 0.14 | 0.96 | 0.001 | 0.02 | ||
| P-value: 6 year versus 1 year | 0.008 | 0.004 | 0.52 | 0.74 | ||
|
| ||||||
| Baseline | −0.25 (−0.97–0.46) | 0.32 (−0.20–0.81) | 0.20 | −0.50 (−1.17–1.18) | 0.33 (−0.16–0.82) | 0.06 |
| 1 year follow up | −0.27 (−1.01–4.64) | 0.27 (−0.23–0.77) | 0.21 | −0.52 (−1.20–0.15) | 0.34 (−0.13–0.80) | 0.05 |
| 6 year follow up | 0.13 (−0.58–0.84) | 0.15 (−0.37–0.66) | 0.97 | 0.1 (−0.66–0.86) | 0.14 (−0.36–0.64) | 0.94 |
| P-value: 1 year versus baseline | 0.74 | 0.57 | 0.54 | 0.95 | ||
| P-value: 6 year versus 1 year | 0.97 | 0.43 | 0.005 | 0.26 | ||
|
| ||||||
| Baseline | 4.7 (4.3–5.0) | 4.6 (4.3–5.0) | 0.94 | 3.7 (3.1–4.2) | 3.8 (3.3–4.3) | 0.01 |
| 1 year follow up | 4.5 (4.1–4.9) | 5.1 (4.0–6.1) | 0.46 | 3.8 (3.3–4.3) | 4.4 (4.1–4.7) | 0.06 |
| 6 year follow up | 5.4 (3.2–7.7) | 4.8 (4.4–5.3) | 0.55 | 4.1 (3.5–4.6) | 4.1 (3.8–4.4) | 0.85 |
| P-value: 1 year versus baseline | 0.34 | 0.41 | 0.46 | 0.35 | ||
| P-value: 6 year versus 1 year | 0.43 | 0.72 | 0.31 | 0.10 | ||